絞り込み

17057

広告

Health Care Resource Utilization and Costs in First-Line Treatments for Patients with Metastatic Melanoma in the United States.

著者 Klink AJ , Chmielowski B , Feinberg B , Ahsan S , Nero D , Liu FX
J Manag Care Spec Pharm.2019 Apr 04 ; ():1-10.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (4view , 0users)

Full Text Sources

Medical

Research Materials

The treatment landscape for patients with metastatic melanoma has changed dramatically with the introduction of novel therapies, such as targeted therapies and immunotherapies, in recent years. Health care resource utilization (HCRU) and cost data are needed to further evaluate these treatments in a value-based health care system.
PMID: 30945965 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード